Result of AGM

RNS Number : 4916D
MyHealthChecked PLC
29 June 2021
 

MyHealthChecked plc

( " MyHealthChecked " or " the Company " )

 

Result of Annual General Meeting

 

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

 

Resolution

(*indicates special resolution)

Votes for1

% of shares voted2

Votes against3

% of shares voted

Resolution 1

145,179,762

99.8%

307,950

0.02%

Resolution 2

145,114,762

99.7%

397,950

0.03%

Resolution 3

145,040,159

99.7%

472,553

0.03%

Resolution 4

144,945,027

99.6%

557,633

0.04%

Resolution 5

144,656,181

99.7%

507,633

0.03%

Resolution 6

144,661,126

99.4%

851,586

0.06%

Resolution 7*

144,332,107

99.2%

1,180,605

0.08%

 

Notes :

1 Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.

2 As a percentage of the aggregate of votes "for" plus votes "against".

3 An abstention is not counted towards the votes cast "for" or "against" a resolution.

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

P enny McCormick , Chief Executive Officer

via Walbrook PR

Gareth Davies, Chief Financial and Operations Officer




SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin




Oberon Capital Ltd (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com



Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

 

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDKCBDKBKDNAB
UK 100

Latest directors dealings